Pyrrole

• May temporarily relieve symptoms associated with sensitivities to phenolic compounds such as rash, fatigue, and lack of concentration.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

DIRECTIONS: Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

1. 1Drug Ineffective3613%
2. 2Fatigue279.7%
3. 3Insomnia238.3%
4. 4Diarrhoea227.9%
5. 5Nausea207.2%
6. 6Asthenia176.1%
7. 7Dyspnoea176.1%
8. 8Fall155.4%
9. 9Headache145.0%
10. 10Anxiety134.7%
11. 11Dizziness134.7%
12. 12Rash134.7%
13. 13Constipation124.3%
14. 14Pain In Extremity114.0%
15. 15Weight Decreased114.0%

Recent PubMed references pinned to Pyrrole as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• The hybrid drug delivery system of TCPP-Co, β-cyclodextrin and piroxicam: Spectroscopic characterization, morphological reorganization and controlled release dynamics.
  Pakistan journal of pharmaceutical sciences · 2026 · Khaliq S, Najaf Iqbal D, Mazher M, et al.
  PMID 42262210DOI 10.36721/PJPS.2026.39.8.236.1
• Associations between vitamin B6 and vitamin B12 intake and lung function: A cross-sectional study based on NHANES 2007 to 2012.
  Medicine · 2026 · Wang W, Gu Y
  PMID 42260844DOI 10.1097/MD.0000000000049118
• Enrichment of Platelet-Rich Fibrin Using Cobalamin and Alpha-Tocopherol to Modulate Growth Factor Release.
  Journal of visualized experiments : JoVE · 2026 · Ozcan M, Saygı H, Alkaya B, et al.
  PMID 42258410DOI 10.3791/71016
• Effects of Light on Faecal Case-bearing Larvae of the Leaf Beetle Chlamisus laticollis (Coleoptera: Chrysomelidae: Cryptocephalinae) Accumulating Phototoxic Chlorophyll Catabolites.
  Journal of chemical ecology · 2026 · Okuzaki Y, Kobayashi K
  PMID 42257740DOI 10.1007/s10886-026-01727-1
• Breakdown products of the fungicide Fludioxonil may account for observed environmental impact: potential implications for human health.
  PeerJ · 2026 · Roelans L, Brandhorst T, Tonelli M, et al.
  PMID 42254677DOI 10.7717/peerj.21290
• Association between proton pump inhibitor use and vitamin B12 deficiency: a retrospective cohort study in primary care centers in Riyadh, Saudi Arabia.
  Annals of Saudi medicine · 2026 · Alanazi S, Bin Sulaiman N, Aldahoul SK, et al.
  PMID 42251516DOI 10.5144/0256-4947.2026.159
• Saroglitazar and vitamin E vs. lifestyle interventions in metabolic dysfunction associated steatotic liver disease: A 3-arm randomised study.
  The Indian journal of medical research · 2026 · Tiwari AK, Singh G, Kumar V, et al.
  PMID 42237829DOI 10.25259/IJMR_2511_2025
• Effect of NSAIDs, melatonin, vitamin D and vitamin B12 chronotherapy on postoperative recovery after third molar surgical extraction: A pilot randomized crossover placebo-controlled trial.
  Oral and maxillofacial surgery · 2026 · Abusamak M, Pérez-González F, Ruiz LV, et al.
  PMID 42230417DOI 10.1007/s10006-026-01582-0

The 8 most recently updated of 8 ClinicalTrials.gov registrations naming Pyrrole as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• RegoNivo vs Standard of Care Chemotherapy in AGOC
  Completed · Phase 3 · Interventional · 462 enrolled · Australasian Gastro-Intestinal Trials Group
  NCT04879368updated 2026-06-10
• EFFECTS OF PYRROLOQUINOLINE QUINONE (PQQ) SUPPLEMENTATION ON NON-ENDURANCE TRAINED ATHLETES
  Completed · Interventional · 24 enrolled · University of Padova
  NCT07148726updated 2025-09-10
• Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
  Active not recruiting · Phase 1 · Interventional · 18 enrolled · Northwestern University
  NCT04047706updated 2025-06-29
• Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
  Active not recruiting · Phase 2 · Interventional · 45 enrolled · Thomas Jefferson University
  NCT03854032updated 2025-06-06
• BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
  Terminated · Phase 1 · Phase 2 · Interventional · 8 enrolled · Edward Kim
  NCT03695250updated 2023-08-22
• Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Rwanda
  Completed · Observational · 3,502 enrolled · PATH
  NCT04230161updated 2023-01-25
• Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Mozambique
  Completed · Observational · 8,726 enrolled · PATH
  NCT04716387updated 2022-12-15
• Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina Faso
  Completed · Observational · 5,606 enrolled · PATH
  NCT04157894updated 2022-12-13

Frequently asked questions

What is Pyrrole used for?

According to FDA labeling, Pyrrole carries indications including: May temporarily relieve symptoms associated with sensitivities to phenolic compounds such as rash, fatigue, and lack of concentration.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.